Scarica l'app Stockscreener
24.12
3.34%
0.78
Pre-mercato:
24.93
0.81
+3.36%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ENOV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$23.34
Aprire:
$23.52
Volume 24 ore:
1.03M
Relative Volume:
1.06
Capitalizzazione di mercato:
$1.39B
Reddito:
$2.25B
Utile/perdita netta:
$-1.18B
Rapporto P/E:
-1.1656
EPS:
-20.6926
Flusso di cassa netto:
$19.92M
1 W Prestazione:
+3.08%
1M Prestazione:
+6.54%
6M Prestazione:
-23.40%
1 anno Prestazione:
-29.39%
Intervallo 1D:
$23.23
$24.70
Intervallo di 1 settimana:
$22.23
$24.70
Portata 52W:
$21.00
$37.85
Enovis Corp Stock (ENOV) Company Profile
Nome
Enovis Corp
Settore
Industria
Telefono
(302) 252-9160
Indirizzo
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
24.12 | 1.39B | 2.25B | -1.18B | 19.92M | -20.69 |
ABT
Abbott Laboratories
|
87.17 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-17 | Ripresa | William Blair | Outperform |
| 2026-01-06 | Iniziato | BTIG Research | Buy |
| 2024-10-03 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-06-13 | Iniziato | JP Morgan | Neutral |
| 2024-02-13 | Iniziato | Stephens | Overweight |
| 2024-01-22 | Iniziato | UBS | Buy |
| 2024-01-03 | Iniziato | William Blair | Outperform |
| 2023-12-15 | Reiterato | Needham | Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-06-26 | Iniziato | Needham | Buy |
| 2023-05-12 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-10-11 | Iniziato | Goldman | Buy |
| 2022-09-12 | Iniziato | Canaccord Genuity | Buy |
| 2022-09-12 | Iniziato | Evercore ISI | Outperform |
| 2022-06-28 | Iniziato | Argus | Hold |
| 2022-06-27 | Ripresa | Loop Capital | Buy |
| 2022-06-16 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Enovis Corp Borsa (ENOV) Ultime notizie
Enovis (ENOV) Q1 Earnings Report Preview: What To Look For - StockStory
Did William Blair’s FCF-Focused ENOV Call Just Shift Enovis’ Investment Narrative? - Yahoo Finance
MSN Money - MSN
Enovis (ENOV) earnings expected to grow: What to know ahead of next week's release - MSN
William Blair’s Focus on Cash Conversion Might Change The Case For Investing In Enovis (ENOV) - simplywall.st
Enovis (NYSE:ENOV) Downgraded by Wall Street Zen to "Hold" - MarketBeat
William Blair Initiates Enovis Corporation Coverage with Outperform Rating - HarianBasis.co
William Blair Assigns Outperform Rating to Enovis (ENOV) - Insider Monkey
Enovis (ENOV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Enovis (ENOV) to Release Earnings on Thursday - MarketBeat
Vanguard reports 5.23% stake in Enovis | ENOV SEC FilingForm SCHEDULE 13G - Stock Titan
LK Balanced Fund's Enovis Corp(ENOV) Holding History - GuruFocus
Vanguard Portfolio Management boosts stake in Enovis (ENOV) to 3.91M shares - Stock Titan
3 Reasons to Sell ENOV and 1 Stock to Buy Instead - The Globe and Mail
Is Enovis Corp (ENOV) a Bargain After 4.7% Drop? GF Value Says U - GuruFocus
Despite fast-paced momentum, Enovis (ENOV) is still a bargain stock - msn.com
Enovis (ENOV) 2024 Wells Fargo Healthcare Conference Summary - Quartr
Enovis Corporation $ENOV Shares Acquired by Impax Asset Management Group plc - MarketBeat
Canaccord Genuity Sticks to Its Buy Rating for Enovis (ENOV) - The Globe and Mail
Enovis (ENOV) 2026 CG Musculoskeletal Conference Summary - Quartr
CCORF Initiates Enovis Corp(ENOV.US) With Buy Rating, Announces Target Price $50 - Moomoo
ENOV (Enovis Corporation) shares rise 4.4 percent after 2025 fourth quarter EPS tops analyst estimates by 13 percent.Trending Buy Opportunities - Cổng thông tin điện tử tỉnh Lào Cai
Despite Fast-paced Momentum, Enovis (ENOV) Is Still a Bargain Stock - Yahoo Finance
Enovis (NYSE:ENOV) Trading Down 7.7%Here's Why - MarketBeat
William Blair Initiates Enovis Corp(ENOV.US) With Buy Rating - 富途牛牛
What could move Enovis Corporation (ENOV) stock later today (+0.27%) 2026-04-20Trending Momentum Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Analyst backs Enovis on cash flow turnaround - MSN
Tributary Capital Management LLC Trims Stake in Enovis Corporation $ENOV - MarketBeat
Deroy & Devereaux Private Investment Counsel Inc. Acquires New Shares in Enovis Corporation $ENOV - MarketBeat
Does The Recent Rebound In Enovis (ENOV) Share Price Reflect Its True Worth? - Yahoo Finance
ENOV Assumed by William Blair -- Rating Maintained as Outperform - GuruFocus
Analyst Backs Enovis On Cash Flow Turnaround - Benzinga
Enovis Coverage Assumed by William Blair at Outperform - Moomoo
Enovis' (ENOV) "Outperform" Rating Reaffirmed at William Blair - MarketBeat
William Blair assumes Enovis stock coverage with outperform rating By Investing.com - Investing.com Australia
William Blair assumes Enovis stock coverage with outperform rating - Investing.com
Enovis assumed with an Outperform at William Blair - TipRanks
Enovis: Discounted Valuation With Clear Free Cash Flow Upside and Product Catalysts Support Buy Rating - TipRanks
Enovis Corporation (NYSE:ENOV) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Is It Time To Reconsider Enovis (ENOV) After Recent Share Price Rebound - simplywall.st
Maplebear to Join S&P MidCap 400 as Enovis Moves to S&P SmallCap 600 in January 2025 - geneonline.com
S&P reshuffle puts Maplebear in MidCap 400, moves Enovis to 600 - Stock Titan
Enovis : Proxy Statement 2026 - marketscreener.com
BTIG Sticks to Its Buy Rating for Enovis (ENOV) - The Globe and Mail
Enovis price target lowered to $39 from $43 at BTIG - TipRanks
BTIG Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $39 - 富途牛牛
Enovis Corp Azioni (ENOV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):